Kane Biotech (KNE) Stock Price, News & Analysis

Company Overview

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

Key Stats

• Today's Range: C$0.03 to C$0.03
• 50-Day Range: C$0.02 to C$0.03
• 52-Week Range: C$0.02 to C$0.05
• Volume: 69,280 shs
• Average Volume: 157,489 shs
• Market Capitalization: C$5.13 million
• P/E Ratio: N/A
• Dividend Yield: 3.08%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: CVE:KNE
• CIK: N/A
• Web: www.kanebiotech.com
• Phone: +1-204-4531301
• Fax: N/A
• Employees: 32
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$6.03 million
• Net Margins: -6,980.20%
• Pretax Margin: N/A
• Return on Equity: 273.53%
• Return on Assets: -58.43%

Debt

• Debt-to-Equity Ratio: -197.52
• Current Ratio: 0.61
• Quick Ratio: 0.39

Sales & Book Value

• Annual Sales: C$38.72 thousand
• Price / Sales: 132.40
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 8.50
• Book Value: C$0.00 per share
• Price / Book: -5.16

Miscellaneous

• Outstanding Shares: 205,057,000
• Free Float: N/A
• Market Cap: C$5.13 million
• Optionable: Not Optionable
• Beta: 0.79